SCALP  CV68- salicylic acid cream 
Pharmco Laboratories, Inc.

----------

Scalp Cream
CV68

Drug Facts

Active Ingredient

Salicylic Acid 3%

Purpose

For the relief of Seborrheic Dermatitis, Dandruff, and/or Psoriasis.

Uses

For the relief of symptoms associated with seborrheic dermatitis, dandruff, and/or psoriasis, including: itching

Helps prevent recurrence.

Warnings

For external use only. Avoid contact with the eyes. If contact occurs, rinse eyes thoroughly with water.

Keep out of reach of children. If swallowed get medical help or call a poison control center immediately.

Directions

Use only as directed. Apply to affected areas one to four times daily or as directed by a doctor. Massage well into affected areas. Optimally, this product should be applied to the scalp and left overnight.

Other Information

Inactive Ingredients

Acrylates/C10-30 Alkyl Acrylate Crosspolymer, BHT, C12-15 Alkyl Benzoate, Carbomer, Diazolidinyl Urea, Disodium EDTA, Glycerin, Methylparaben, Propylene Glycol, Propylparaben, Prunus Amigdalus Dulcis (Sweet Almond) Oil, Sesamum Indicum (Sesame) Seed Oil, Sodium Hydroxide, Sorbitan Oleate, Triethanolamine, Water.

Questions or comments?

call 1.800.635.0712 Monday through Friday 8:00 AM to 4:30 PM

Manufactured by: Pharmco Laboratories, Inc.
3520 South St. • Titusville, FL 32780

PRINCIPAL DISPLAY PANEL - 96 g Bottle Label

PHARMCO
SKINCARE LABS

Scalp Cream

Helps Control
SEBORRHEIC DERMATITIS,
DANDRUFF & PSORIASIS

Net wt. 3.4 oz. (96 g)

PRINCIPAL DISPLAY PANEL - 96 g Bottle Label
SCALP   CV68
salicylic acid cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:58400-020
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Salicylic Acid (UNII: O414PZ4LPZ) (Salicylic Acid - UNII:O414PZ4LPZ) Salicylic Acid30 mg  in 1 g
Inactive Ingredients
Ingredient NameStrength
CARBOMER COPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED) (UNII: 71DD5V995L)  
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)  
ALKYL (C12-15) BENZOATE (UNII: A9EJ3J61HQ)  
CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE (UNII: 0A5MM307FC)  
Diazolidinyl Urea (UNII: H5RIZ3MPW4)  
EDETATE DISODIUM ANHYDROUS (UNII: 8NLQ36F6MM)  
Glycerin (UNII: PDC6A3C0OX)  
Methylparaben (UNII: A2I8C7HI9T)  
Propylene Glycol (UNII: 6DC9Q167V3)  
Propylparaben (UNII: Z8IX2SC1OH)  
ALMOND OIL (UNII: 66YXD4DKO9)  
SESAME OIL (UNII: QX10HYY4QV)  
Sodium Hydroxide (UNII: 55X04QC32I)  
SORBITAN MONOOLEATE (UNII: 06XEA2VD56)  
CUPRIC BIS(TRIETHANOLAMINE) (UNII: YBM44X0B6H)  
Water (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:58400-020-0196 g in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph drugM03201/01/2018
Labeler - Pharmco Laboratories, Inc. (096270814)
Establishment
NameAddressID/FEIBusiness Operations
Pharmco Laboratories, Inc.096270814MANUFACTURE(58400-020) , LABEL(58400-020) , PACK(58400-020)

Revised: 1/2024
Document Id: bc4a79f9-8e7d-4f77-8563-70fbf897e0df
Set id: cbc12765-5fbd-4ac0-938e-0e90d1397a03
Version: 2
Effective Time: 20240112
 
Pharmco Laboratories, Inc.